Neogen Chemicals Limited, a prominent player in India's specialty chemicals sector, recently took a significant step toward funding its ambitious expansion into battery materials by conducting an extraordinary general meeting (EGM) on March 29, 2026. The meeting, held entirely via video conferencing, focused on a single agenda: the preferential issuance of equity shares to members of the company’s promoter group. This move, which has drawn keen attention from market watchers and shareholders alike, comes at a pivotal moment for Neogen, as it seeks to balance growth aspirations with current financial headwinds.
The EGM, chaired by Mr. Anurag Surana (Chairman and Non-Executive Director), ran efficiently from 11:30 a.m. to 11:56 a.m. IST. According to official company communications, shareholders, directors, and auditors joined through an electronic platform provided by MUFG Intime India Private Limited. Company Secretary Unnati Kanani opened the proceedings, ensuring regulatory protocols were meticulously followed. The meeting’s structure and transparency were further bolstered by the appointment of CS Devendra V. Deshpande from DVD & Associates as scrutinizer, a role critical for overseeing the voting process and ensuring fairness.
Remote e-voting had been made available from March 26 to March 28, 2026, allowing shareholders ample opportunity to cast their votes ahead of the EGM. For those who hadn’t voted remotely, e-voting was facilitated during the meeting itself—though, as per strict guidelines, members who voted remotely could not vote again, and remote votes took precedence in case of duplication. The company announced that consolidated voting results would be published within 48 hours on its website, as well as on the platforms of BSE Limited, National Stock Exchange of India Limited, and the registrar’s website, ensuring comprehensive stakeholder access.
The heart of the meeting was a special resolution to issue 1 million equity shares on a preferential basis to the promoter group at ₹1,610 per share. This price stands out for being 17.02% above the SEBI-mandated floor price of ₹1,375.82, reflecting a substantial premium and signaling strong promoter confidence. The shares, once allotted, will be locked in for 18 months from the date trading approval is granted—a measure aimed at providing stability and aligning promoter interests with the company’s long-term prospects.
During the EGM, Managing Director Dr. Harin Kanani addressed a range of shareholder queries, covering the rationale behind the share issuance, the planned utilization of proceeds, the existing shareholding patterns (including those of foreign investors), and the potential impact of ongoing geopolitical uncertainties on operations. According to the company’s detailed corrigendum, the funds raised—totalling approximately ₹161 crore—are earmarked for three main purposes: ₹100 crore will be invested in Neogen Ionics Limited (NIL), a wholly-owned subsidiary focused on battery chemicals; ₹21 crore will support working capital requirements; and ₹40 crore will be allocated to general corporate purposes. All funds are slated for deployment within 90 days of the share allotment, with a provision for minor variations of up to 10% in each category.
Neogen Ionics Limited, incorporated in March 2023, is central to the company’s strategic pivot toward lithium-ion battery materials. The subsidiary has already acquired about 65 acres of land in Dahej, Gujarat, and plans to establish a major battery materials facility. The broader project, with an estimated total capital expenditure of ₹1,500 crore, aims to create a production capacity of 30,000 metric tons per annum (MTA) of electrolyte using licensed MUIS Technology, along with 3,000 MTA of specialty lithium electrolyte salts and additives at Pakhajan, and additional facilities at Dahej SEZ. If successful, the project could deliver peak revenues of ₹2,500–2,950 crore, positioning Neogen as a significant player in the battery materials market.
However, this bold expansion comes amid notable financial pressure. As reported in recent financial disclosures, Neogen Chemicals’ consolidated net profit dropped sharply by 63.1% to ₹3.69 crore in the third quarter of fiscal 2026, even as revenue climbed 9.2% to ₹220 crore. Earnings per share have tumbled from ₹20.04 in FY24 to just ₹1.28 in FY26, underscoring the company’s struggle to translate top-line growth into sustainable profits. The company’s forward price-to-earnings (P/E) ratio stands at a lofty 158.76, highlighting high market expectations but also leaving little room for error if the battery project faces setbacks or delays.
Shareholders and analysts are understandably watching closely. The preferential issue’s premium pricing and lock-in period suggest the promoters’ confidence in Neogen’s long-term trajectory, but they also raise questions about potential dilution of minority shareholder rights and the risk-reward calculus for existing investors. The company’s recent stock performance has reflected these uncertainties, with a one-year return of -27.67% and a five-year gain of 48.76%—a mixed record that underscores both the volatility and the potential upside if the battery materials strategy pays off.
Further complicating matters, the company has had to navigate regulatory complexities. The EGM notice, dated March 7, 2026, and a subsequent corrigendum on March 17, 2026, were distributed to all shareholders and posted on the company’s website. Newspaper advertisements regarding the corrigendum were published on March 18, 2026, in both Financial Express and Mumbai Lakshadeep, ensuring full transparency. The corrigendum also detailed inter-se transfers of shares among promoter family trusts, executed under SEBI exemption orders, and clarified the status of Cadamba Solutions Private Limited—a newly incorporated promoter group entity set to receive the entire 1 million-share allotment.
For investors, the next few quarters will be critical. The company has committed to deploying the ₹100 crore investment in Neogen Ionics within 90 days of share allotment, and any delay or deviation from this timeline will be closely scrutinized. The market will also be watching for updates on construction progress, the start of commercial production, and the ability to secure customers in the fast-growing but competitive battery materials sector. Financial results in the coming quarters will serve as early indicators of whether the capital raised is being effectively deployed and whether the ambitious revenue targets are within reach.
All told, Neogen Chemicals’ preferential share issue marks a high-stakes bet on the future of battery materials—a sector with enormous potential but equally significant execution risks. The company’s ability to deliver on its promises, manage operational headwinds, and maintain shareholder confidence will determine whether this moment is remembered as a turning point or a cautionary tale in India’s evolving chemicals industry.